The Scripps Research Institute (TSRI) — one of the world's largest, private, non-profit research organizations — stands at the forefront of basic biomedical science, a vital segment of medical research that seeks to comprehend the most fundamental processes of life.
Over the last decades, the institute has established a lengthy track record of major contributions to the betterment of health and the human condition.
The institute — located on campuses in La Jolla, California, and Jupiter, Florida — has become internationally recognized for its research into immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune diseases, cardiovascular diseases, virology, and vaccine development. Particularly significant is the institute's study of the basic structure and design of biological molecules; in this arena TSRI is among a handful of the world's leading centers.
Rather than isolating faculty members, students, and laboratories into separate and distinct disciplines, as in many universities, a cooperative, collaborative spirit is encouraged and embraced. While the level of scientific investigation is intense, the atmosphere is collegial, relaxed, and informal. Technicians, postdoctoral fellows, graduate students, and administrative support staff all are considered part of the team and are given the latitude and responsibility to accomplish their tasks to serve the best interests of science. The pursuit of scientific excellence is paramount and all efforts are directed toward that end.
TSRI’s philosophy emphasizes the creation of basic knowledge in the biosciences for its application in medicine, the pursuit of fundamental scientific advances through interdisciplinary programs and collaborations, and the education and training of researchers preparing to meet the scientific challenges of the future.
The Scripps Research Institute has two campuses: its headquarters in La Jolla, CA, and a facility in Jupiter, FL.
The more than 200 principal investigators at TSRI include many distinguished leaders in their fields who have won numerous awards and honors, including two Nobel Prizes and election to a variety of honorary societies.
While academic divisions are de-emphasized across the institute to encourage collaboration, each faculty member belongs to an academic department. A variety of academic centers and consortia also exist within the institute.
TSRI faculty are among the most prolific and entrepreneurial in the world, with:
Learn more about TSRI’s Scientific Achievements.
In addition to the training of hundreds of postdoctoral fellows (see Postdoctoral Services), TSRI offers a distinguished graduate program in the biological and chemical sciences as well as outreach programs for high school and middle school students, teachers, and undergraduates.
Launched in 1989, TSRI’s Graduate Program is ranked among the top graduate schools in the country according to a number of metrics, including U.S. News & World Report. The publication now ranks TSRI’s Graduate Program seventh overall in chemistry, with a ranking of sixth in the specialty of organic chemistry and second in the specialty of biochemistry. The school is also rated ninth overall in the biological sciences. The school can now boast more than 500 accomplished alumni, who work in both academics and industry. For more information, see the Graduate Program webpage.
In addition, TSRI provides opportunities for younger students and their teachers to learn more about science and scientific careers. From internships to workshops, outreach activities aim to generate excitement about the power and potential of the biomedical sciences. For more information, see Outreach Programs.
TSRI aims to attract faculty and staff at the top of their fields. Currently, the institute employs more than 2,600 people:
Staff scientists: 65
Research associates: 353
Scientific and administrative support: 680
Adjunct, emeritus, visiting appointments: 297
TSRI graduate students: 185
Interns, trainees, etc: 277
California Total: 2,047
Staff scientists: 22
Research associates: 159
Scientific and administrative support: 207
Adjunct, emeritus, visiting appointments: 18
TSRI graduate students: 49
Interns, trainees, etc: 92
Florida Total: 600
(Updated quarterly: Figures as of March 31, 2016)
For more information on joining our team, see Careers.
Grants and contracts provide funding for a significant portion of the institute's research activities. This revenue is derived primarily from the National Institutes of Health and other federal agencies. In addition, grantors include, among others, the American Cancer Society, the American Heart Association, the Cystic Fibrosis Foundation, the Leukemia & Lymphoma Society, and the Juvenile Diabetes Association.
Partnerships with industry provide additional revenue for research, while advancing new therapies for patients in need. TSRI currently has more than 30 active partnerships. These partners have included Pfizer, Bristol-Myers Squibb, Novartis and Johnson & Johnson. For more information on licensing and partnership opportunities, see the Office of Technology Development.
Gifts from individuals and private foundations also provide an important source of funding for TSRI. For more information on supporting the institute, see Making a Difference Together.
Financial statements (pdf) are available for the year ending:
The establishment of the Scripps Florida campus was made possible by a one-time $310 million appropriation of federal economic development funds and by the Florida State Legislature and by an economic package provided by Palm Beach County.